The Collar Sign in Pipeline Embolization Device–Treated Aneurysms

References

1. 1.↵
   1. Becske T,
   2. Brinjikji W,
   3. Potts MB, et al

   . Long-term clinical and angiographic outcomes following Pipeline embolization device treatment of complex internal carotid artery aneurysms: five-year results of the Pipeline for Uncoilable or Failed Aneurysms trial. Neurosurgery 2017;80:40–48 doi:10.1093/neuros/nyw014 pmid:28362885

   CrossRefPubMed
2. 2.↵
   1. Griessenauer CJ,
   2. Gupta R,
   3. Shi S, et al

   . Collar sign in incompletely occluded aneurysms after Pipeline embolization: evaluation with angiography and optical coherence tomography. AJNR Am J Neuroradiol 2017;38:323–26 doi:10.3174/ajnr.A5010 pmid:28056454

   Abstract/FREE Full Text
3. 3.↵
   1. Derdeyn CP,
   2. Fiorella D,
   3. Lynn MJ, et al

   ; SAMMPRIS Investigators. Nonprocedural symptomatic infarction and in-stent restenosis after intracranial angioplasty and stenting in the SAMMPRIS trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis). Stroke 2017;48:1501–06 doi:10.1161/STROKEAHA.116.014537 pmid:28455321

   Abstract/FREE Full Text
4. 4.↵
   1. Rouchaud A,
   2. Ramana C,
   3. Brinjikji W, et al

   . Wall apposition is a key factor for aneurysm occlusion after flow diversion: a histological evaluation in 41 rabbits. AJNR Am J Neuroradiol 2016;37:2087–91 doi:10.3174/ajnr.A4848 pmid:27390319

   Abstract/FREE Full Text
5. 5.↵
   1. Shapiro M,
   2. Becske T,
   3. Nelson PK

   . Learning from failure: persistence of aneurysms following pipeline embolization. J Neurosurg 2017;126:578–85 doi:10.3171/2015.12.JNS152065 pmid:27153168

   CrossRefPubMed
6. 6.↵
   1. Akbari HS,
   2. Reynolds MR,
   3. Kadkhodayan Y, et al

   . Hemorrhagic complications after prasugrel (Effient®) therapy for vascular neurointerventional procedures. J Neurointerv Surg 2013;5:337–43 doi:10.1136/neurintsurg-2012-010334 pmid:22555594

   Abstract/FREE Full Text
7. 7.↵
   1. Gandhi CD,
   2. Bulsara KR,
   3. Johanna F, et al

   ; SNIS Standards and Guidelines Committee. Platelet function inhibitors and platelet function testing in neurointerventional procedures. J Neurointerv Surg 2014;6:567–77 doi:10.1136/neurintsurg-2014-011357 pmid:25056369

   FREE Full Text
8. 8.↵
   1. Plamaz JC

   . Intravascular stents: tissue-stent interactions and design consideration. AJR Am J Roentgenol 1993;160:613–18 doi:10.2214/ajr.160.3.8430566 pmid:8430566

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Gomez-Paz S,
   2. Akamatsu Y,
   3. Moore JM, et al

   . Implications of the collar sign in incompletely occluded aneurysms after Pipeline Embolization Device: a follow-up study. AJNR Am J Neuroradiol. In press
10. 10.↵
    1. Jabbour P,
    2. Chalouhi N,
    3. Tjoumakaris S, et al

    . The Pipeline Embolization Device: learning curve and predictors of complications and aneurysm obliteration. Neurosurgery 2013;73:113–20 doi:10.1227/01.neu.0000429844.06955.39 pmid:23615106

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Kadirvel R,
    2. Ding YH,
    3. Dai D, et al

    . Cellular mechanisms of aneurysm occlusion after treatment with a flow diverter. Radiology 2014;270:394–99 doi:10.1148/radiol.13130796 pmid:24086073

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Dai D,
    2. Ding YH,
    3. Kelly M, et al

    . Histopathological findings following Pipeline embolization in a human cerebral aneurysm at the basilar tip. Interv Neuroradiol 2016;22:153–57 doi:10.1177/1591019915622165 pmid:26842611

    CrossRefPubMed
13. 13.↵
    1. Matsuda Y,
    2. Chung J,
    3. Lopes DK

    . Analysis of neointimal development in flow diverters using optical coherence tomography imaging. J Neurointerv Surg 2018;10:162–67 doi:10.1136/neurintsurg-2016-012969 pmid:28592484

    Abstract/FREE Full Text